JHP and SpePharm acquire Dantrium from P&G
Executive Summary
Procter & Gamble has sold its muscle relaxant Dantrium (dantrolene) to JHP Pharmaceuticals (sterile injectable drugs for the hospital market) and Dutch specialty pharmaco SpePharm Holding BV.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice